• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-SIRT2

SIRT2 Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, porc, rat, souris

Applications

WB, IHC, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1D8G10

N° de cat : 66410-1-PBS

Synonymes

SIR2, SIR2 like protein 2, SIR2L, SIR2L2, SIRT2



Informations sur le produit

66410-1-PBS cible SIRT2 dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc, rat, souris

Réactivité Humain, porc, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène SIRT2 Protéine recombinante Ag7756
Nom complet sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)
Masse moléculaire calculée 43 kDa
Poids moléculaire observé 37-45 kDa
Numéro d’acquisition GenBankBC003547
Symbole du gène SIRT2
Identification du gène (NCBI) 22933
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The silent information regulator(SIR2) family of genes is highly conserved from prokaryotes to eukaryotes and is involved in diverse processes, including transcriptional regulation, cell cycle progression, DNA damage repair, and aging. SIR2 contains a 323 amino acid catalytic core domain with a NAD-binding domain and a large groove which is the likely site of catalysis. SIR2 is widely expressed and highly expressed in the heart, brain, and skeletal muscle, while it is weakly expressed in the placenta and lungs. Down-regulated in many gliomas suggesting that it may act as a tumor suppressor gene in human gliomas possibly through the regulation of the microtubule network. SIRT2 exists in various isoforms and the molecular weight of isoforms are 35 kDa, 40 kDa, and 42 kDa.

{{ptg:RelatedPrimaryAntibodies}}